Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Longitudinal evaluation of serum leptin and bone mineral density in early postmenopausal women.

Di Carlo C, Tommaselli GA, Di Spiezio Sardo A, Sammartino A, Attianese W, Gargano V, Bifulco G, Nappi C.

Menopause. 2007 May-Jun;14(3 Pt 1):450-4.

PMID:
17242633
2.

Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.

Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, Bifulco G, Cirillo D, Guida M, Capasso R, Nappi C.

Menopause. 2006 Jul-Aug;13(4):660-8.

PMID:
16837888
3.

Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy.

Di Carlo C, Tommaselli GA, Sammartino A, Bifulco G, Nasti A, Nappi C.

Menopause. 2004 Jul-Aug;11(4):466-73.

PMID:
15243285
4.
5.

Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two-year study.

Watts NB, Nolan JC, Brennan JJ, Yang HM; ESTRATAB/Osteoporosis Study Group.

Menopause. 2000 Nov-Dec;7(6):375-82.

PMID:
11127759
6.

Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.

Gambacciani M, Cappagli B, Ciaponi M, Pepe A, Vacca F, Genazzani AR.

Maturitas. 2008 Jan 20;59(1):2-6. Epub 2007 Dec 3.

PMID:
18063490
7.
8.
9.

[Comparison of changes in biochemical markers of bone turnover after 6 months of hormone replacement therapy with either transdermal 17 beta-estradiol or equine conjugated estrogen plus nomegestrol acetate].

Collette J, Viethel P, Dethor M, Chevallier T, Micheletti MC, Foidart JM, Reginster JY.

Gynecol Obstet Fertil. 2003 May;31(5):434-41. French.

PMID:
14567121
10.

Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy.

Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Genazzani AR.

Maturitas. 2003 Jul 25;45(3):175-83.

PMID:
12818462
11.

A follow-up study on the effects of a milk supplement on bone mineral density of postmenopausal Chinese women in Malaysia.

Ting GP, Tan SY, Chan SP, Karuthan C, Zaitun Y, Suriah AR, Chee WS.

J Nutr Health Aging. 2007 Jan-Feb;11(1):69-73.

PMID:
17315084
12.

Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy.

Di Carlo C, Tommaselli GA, Pisano G, Nasti A, Rossi V, Palomba S, Nappi C.

Menopause. 2000 Jan-Feb;7(1):36-41.

PMID:
10646702
13.

Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.

Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.

Metabolism. 2009 Jan;58(1):1-7. doi: 10.1016/j.metabol.2008.07.016.

PMID:
19059524
15.
16.

Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.

Sethi BK, Chadha M, Modi KD, Kumar KM, Mehrotra R, Sriram U.

J Assoc Physicians India. 2008 Jun;56:418-24.

PMID:
18822620
17.

Percutaneous estrogen in prevention of early postmenopausal bone loss in Chinese women.

Sun A, Lin S, Yu W, Qin M, Chen F, Zhang Y, Wei Y, de Lignieres B.

Chin Med J (Engl). 2002 Dec;115(12):1790-5.

PMID:
12622925
18.

The effects of transdermal estrogen therapy on bone mass and turnover in early postmenopausal smokers: a prospective, controlled study.

Välimäki MJ, Laitinen KA, Tähtelä RK, Hirvonen EJ, Risteli JP.

Am J Obstet Gynecol. 2003 Nov;189(5):1213-20.

PMID:
14634543
19.

Bone density changes in postmenopausal women with the administration of ipriflavone alone or in association with low-dose ERT.

de Aloysio D, Gambacciani M, Altieri P, Ciaponi M, Ventura V, Mura M, Genazzani AR, Bottiglioni F.

Gynecol Endocrinol. 1997 Aug;11(4):289-93.

PMID:
9272427
20.

Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women.

Stomati M, Bersi C, Rubino S, Palumbo M, Comitini G, Genazzani AD, Santuz M, Petraglia F, Genazzani AR.

Maturitas. 1997 Dec 15;28(2):127-35. Erratum in: Maturitas 1998 Jun 17;29(3):271. Santre M [corrected to Santuz M].

PMID:
9522320

Supplemental Content

Support Center